Relations of Plasma High-Sensitivity C-Reactive Protein to Various Cardiovascular Risk Factors by Ryu, So Yeon et al.
INTRODUCTION
There is increasing evidence that higher levels of high-sen-
sitivity C-reactive protein (hsCRP) is a predictor of cardiovas-
cular disease (CVD), and may play an important role in the
different stages of the development of atherosclerosis (1, 2).
The predictive value of CRP was found in apparently healthy
subjects (3, 4), in patients with established CVD (5), in sev-
eral subgroups of the general population (6) and both in men
and women (7).
In healthy subjects even a moderate increase of hsCRP
within the normal range (hsCRP <5 mg/L) is considered to
be predictive for a variety of cardiovascular events, indepen-
dent from other cardiovascular risk factors (1, 2, 10). The
mechanism responsible for this acute phase response in CVD
is not yet completely understood. The association between
inflammatory markers and other risk factors of CVD, such
as age, gender, smoking habits, obesity, diabetes mellitus,
education level and social class, low and high-density lipopro-
tein-cholesterol, high levels of triglycerides, insulin resistance
and physical activity supports the idea that the inflammato-
ry markers might be the expression of intermediate mecha-
nisms (7, 9-11).
In order to prevent the incidence of CVD effectively, it is
important to weigh the influence of each risk factor on the
cardiovascular system. In this context, it must be taken into
consideration that various cardiovascular factors are not inde-
pendent of one another, but have direct or indirect relations
(7). For example, the prevalence of hypertension increases
with age and hyperlipidemia or glucose intolerance lead to
hypertension, which is another main risk factor for coronary
heart disease. Effective prevention of CVD should be started
with unraveling the network of multiple risk factors (7). The
reduction of cardiovascular risk by lifestyle changes, such as
diet, weight loss, exercise and smoking cessation has been
linked to lower hsCRP levels (11, 12).
In this respect, the relation of inflammation markers to
other risk factors are not well understood. Few studies, how-
ever, have explored interrelations between levels of CRP and
other cardiovascular risk factors, and data from these reports
have been inconsistent (13). So this study was performed to
identify the relationship between serum hsCRP and tradition-
al cardiovascular risk factors of the community health-check
survey participants in a rural area.
MATERIALS AND METHODS
Study subjects
Two-hundred two subjects participated the questionnaire
survey and health examination program and aged 50 and over
So Yeon Ryu, Young Sun Lee*,
Jong Park, Myeng Geun Kang,
Ki Soon Kim
Department of Preventive Medicine, Chosun University
College of Medicine, Department of Public Health*,
Graduate School of Chosun University, Gwangju,
Korea
Address for correspondence
So Yeon Ryu, M.D.
Department of Preventive Medicine, Chosun University
College of Medicine, 375 Seosuk-dong, Dong-gu,
Gwangju 501-759, Korea
Tel : +82.62-230-6483, Fax : +82.62-225-8293
E-mail : canrsy@chosun.ac.kr
*This work was supported by research funds from
Chosun University, 2002.
379
J Korean Med Sci 2005; 20: 379-83
ISSN 1011-8934
Copyright � The Korean Academy
of Medical Sciences
Relations of Plasma High-Sensitivity C-Reactive Protein to Various
Cardiovascular Risk Factors
This study was performed to evaluate the relation of high-sensitivity C-reactive pro-
tein (hsCRP) with several cardiovascular risk factors such as age, blood pressure,
smoking habit and serum lipids, body mass index, blood glucose, regular exercise,
alcohol drinking, white blood cell counts in a cross-sectional survey. Plasma hsCRP
was measured by immunoturbidimetry in 202 subjects, aged over 50 yr, who partic-
ipated in health-check survey in a rural area of Jeollanamdo, Korea. Plasma hsCRP
level was 1.9±3.0 mg/dL. There were significant associations between hsCRP levels
and age, white blood cell counts, blood glucose, diastolic blood pressure, HDL-cho-
lesterol, body mass index and smoking status. In stepwise multivariate regression
analysis, white blood cell counts, age, blood glucose, smoking status and body mass
index were independent correlates of hsCRP levels. In conclusion, plasma hsCRP
levels were associated with several cardiovascular risk factors, and these data are
compatible with the hypothesis that CRP levels may be a marker for preclinical car-
diovascular disease. Further what we need now are prospective studies to evalu-
ate the association of C-reactive protein concentrations with subsequent cardiac
events.
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years. They are residents in Changneong, Singi, Mokchon,
Pyungsa and Singeon villages of Suncheon city, Jeollanamdo.
They are supposedly interested in their health state because
they voluntarily applied to this survey program. Of 202 sub-
jects examined in this study, few subjects had diseases history
(coronary heart disease, stroke, chronic renal failure, cancer,
etc.) except hypertension and plasma levels of log-transformed
hsCRP were not different between subjects without diag-
nosed diseases and subjects with diseases. So we analyzed all
202 subjects who participated in this survey. 
Data collection methods
The program of this study included the questionnaire sur-
vey, physical examination and laboratory examinations, such
as, blood cell counts, blood lipid profiles and blood chem-
istry. The physical examination and blood sampling were
performed by trained study staffs who were composed of med-
ical student, nursing students and nurses.
Information about socio-demographic variables such as age,
sex, educational level, socioeconomic status, marital status,
experiences of cigarette smoking and alcohol consumptions
was obtained by a self-administered questionnaire. Body mass
index (BMI) was calculated as weight (kg) divided by height
squared (m2). Blood pressure was measured twice on at least
5-min interval by mercury sphygmomanometer with the sub-
ject in a sitting position and the averaged value was used for
analyses.
Antecubital venous blood was collected into a plain tube
and a tube containing EDTA (1 mg/mL) in the morning
after the subjects had fasted overnight. Plasma was separat-
ed by centrifugation at 4℃ and stored at -80℃ until assayed.
Routine laboratory tests, including blood cell counts, blood
lipid profiles and blood chemistry, were performed using auto-
matic analyzers. Plasma levels of hsCRP were measured by a
immunoturbidimetry on Cobas Integra 700 analyser (Roche,
Germany). For hsCRP, we used reagents containing specific
monoclonal (CRP) antibody coated to polystyrene particles
(Roche).
Statistical analysis
SPSS, version 9.0 (SPSS Inc., Chicago, IL, U.S.A.) was used
for all statistical calculations. Characteristics of the study sub-
jects were expressed by means and standard deviations for
continuous variables. Categorical variables were presented
as absolute and relative frequencies. Due to the skewed dis-
tribution of hsCRP levels, we used its natural log-transfor-
mation in the analysis and presented geometric mean and
geometric standard deviation. Comparisons between general
and clinical characteristics and sex were performed by Student
t-test and chi-square test. Natural log-transformed hsCRP
levels of three or more groups were compared using analysis
of variance (ANOVA) followed by Scheffe’s post hoc test. Cor-
relation coefficients between hsCRP and continuous variables
were calculated by Pearson’s correlation analysis and partial
correlation coefficients were computed after adjustment for
age. Finally stepwise multiple linear regression analysis was
used to evaluate relationships between hsCRP and cardiovas-
cular risk factors. The dichotomous variable such as smoking
experience was put into categories, 0 (no) and 1 (yes). A p-value
of <0.05 was considered to indicate statistical significance.
RESULTS
General characteristics of the 202 subjects, 75 men and 127
women, are listed in Table 1. There were statistically differ-
ent distributions in general characteristics between men and
women. In particular, men had higher educational level, more
married status, more frequent smoking and alcohol drinking
experiences.
There were well-expected differences in physical and lab-
oratory findings between men and women. Men had higher
white blood cell count, hemoglobin, hematocrit, and total
cholesterol levels and lower HDL-cholesterol and LDL-choles-
terol levels than women. HsCRP levels, however, was not sig-
nificantly different between men and women (Table 2).
Table 3 shows geometric means and geometric standard
deviations of hsCRP levels according to general characteris-
tics. HsCRP levels were significantly higher in persons who
had smoking experience. 
Table 4 shows the results of unadjusted and age-adjusted
correlation analyses of factors relating to log-transformed
hsCRP level. Plasma hsCRP level had significant positive cor-
relation with age, body mass index, diastolic blood pressure,
fasting blood glucose and white blood cell counts. Although
the correlation between plasma hsCRP and HDL-cholesterol
was negatively significant, other blood lipid profile, such as
Variables Class Men Women p-value
Educational level No 18 (24.0) 80 (63.0) 0.000
Primary school 30 (40.0) 37 (29.1)
Middle school 17 (22.7) 5 (3.9)
High school + 10 (13.3) 5 (3.9)
Marital status Married 72 (96.0) 84 (66.1) 0.000
Divorced, or others 3 (4.0) 43 (33.9)
Socio-economic level Mid-upper 6 (8.0) 7 (5.5) 0.657
Middle 45 (60.0) 73 (57.5)
Low 24 (32.0) 47 (37.0)
Smoking status No 26 (34.7) 124 (97.6) 0.000
Yes 49 (65.3) 3 (2.4)
Alcohol drinking No 25 (33.3) 81 (63.8) 0.000
Yes 50 (66.7) 46 (36.3)
Age (yr) mean (SD)* 64.8 (9.4) 65.0 (10.5) 0.888
Total 75 (37.1) 127 (62.9)
Table 1. General characteristics of the study subjects 
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total cholesterol, triglyceride and LDL-cholesterol did not
significantly correlate with hsCRP. Adjustment for age had
minimal impact on these association.
The results of stepwise multiple regression analysis is shown
in Table 5. In stepwise multiple regression analysis, white
blood cell counts, age, fasting blood glucose, smoking and
body mass index remained as factors showing independent
association with plasma hsCRP, and these factors accounted
for 16.5% of the variance in hsCRP levels.
DISCUSSION
Several prospective epidemiologic studies have demonstrat-
ed a positive association between CRP levels and the risk of
future cardiovascular disease (14). Risk factors of cardiovas-
cular diseases are often related to one another. For example,
hypertension is often associated with glucose intolerance and
hypercholesterolemia. Simple reduction of blood pressure or
lowering of serum lipids alone may reduce the risk of cardio-
vascular diseases to some extent (15). Therefore, in order to
prevent the occurrence of cardiovascular diseases more effec-
tively, comprehensive reductions of cardiovascular risk fac-
tors should be considered, and it is important to understand
the interrelationship of each risk factor (7).
With regard to the pathogenesis of cardiovascular diseases,
the inflammatory response is now considered to be indepen-
dent risk factor to the development of cardiovascular diseases
(16). Especially inflammatory components are believed to
contribute greatly to instability and rupture of atheromatous
plaque that leads to atherothrombotic events (17, 18). 
CRP is an acute phase reactant, which is marker for under-
lying systemic inflammation. When measured with a high
sensitivity assay, CRP levels also appear to have predictive
value for cardiovascular morbidity and mortality. Moreover,
baseline levels of CRP predict the risk of future myocardial
infarction, stroke, and peripheral atherosclerosis, even after
adjustment for other known cardiovascular risk factors (14).
So in this study, we investigated the factors relating to the
plasma hsCRP level. As a result of our analysis, white blood
cell counts, age, fasting blood glucose, smoking and body
mass index are the independent factors relating to plasma
hsCRP level. In addition, blood pressure (BP) and HDL-
cholesterol level also had significant correlations with plasma






Body mass index (kg/m
2) 24.3±2.9 24.9±3.2 0.185
Systolic blood pressure (mmHg) 144.4±24.3 141.6±22.9 0.426
Diastolic blood pressure (mmHg) 87.1±14.0 85.6±12.3 0.418
Pulse pressure (mmHg) 57.3±14.5 56.1±14.8 0.579
White blood cel count (×10
3/ L) 6.7±1.8 5.8±1.5 0.000
Blood hemoglobin (g/dL) 14.5±1.5 13.0±1.1 0.000
Hematocrit (%) 43.1±6.5 38.4±2.9 0.000
Total cholesterol (mg/dL) 195.7±39.9 212.4±40.4 0.005
Triglyceride (mg/dL) 182.0±107.2 160.6±81.3 0.138
HDL-cholesterol (mg/dL) 48.1±13.7 53.6±11.3 0.002
LDL-cholesterol (mg/dL) 110.2±36.9 126.2±33.6 0.002
Blood glucose (mg/dL) 137.9±47.0 131.7±39.3 0.311
hsCRP (mg/L) 2.4±3.9 1.6±2.3 0.089
Table 2. Physical and laboratory findings of the study subjects
Variables Category hsCRP* p-value
Educational level Non 1.20 (2.57) 0.261
Primary school 0.95 (2.73)
Middle school 0.93 (2.33)
High school + 0.86 (2.34)
Marital status Married 1.07 (2.62) 0.645
Divorced, or others 0.97 (2.49)
Socioeconomic status Mid-upper + 0.95 (2.14) 0.820
Middle 1.04 (2.60)
Low 1.11 (2.67)
Smoking status No 0.95 (2.38) 0.021
Yes 1.42 (3.06)
Alcohol drinking No 1.03 (1.49) 0.824
Yes 1.02 (1.54)
Table 3. The association of hsCRP with general characteristics






Age 0.170 0.016 -
Body mass index 0.178 0.011 0.206 0.003
Systolic blood pressure 0.120 0.090 0.080 0.257
Diastolic blood pressure 0.167 0.018 0.153 0.030
Pulse pressure 0.044 0.534 -0.010 0.884
Total cholesterol 0.036 0.608 0.038 0.589
Triglycerides 0.094 0.185 0.111 0.118
HDL*-cholesterol -0.191 0.007 -0.170 0.016
LDL
� -cholesterol 0.056 0.432 0.041 0.560
Fasting blood glucose 0.202 0.004 0.192 0.006
White blood cell count 0.227 0.001 0.248 0.000
Table 4. Unadjusted and age-adjusted correlation coefficients
between log hsCRP levels and various factors in the subjects
*HDL, high density lipoprotein; 
� LDL, low density lipoprotein.
Variables Standardized coefficients p-value
White blood cell count 0.163 0.018
Age 0.205 0.002
Fasting blood glucose 0.150 0.026
Smoking (yes/no) 0.184 0.007
Body mass index 0.165 0.016
Table 5. Stepwise multiple regression analysis of relations of var-
ious cardiovascular risk factors to hsCRP log transformed in the
subjects
R
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supporting the importance of inflammation in atherogenesis.
Similarly, these data suggest important relationships between
inflammation and traditional cardiovascular risk factors.
Inflammation has been hypothesized to play a role in the
development of hypertension, and several cross-sectional stud-
ies demonstrate higher CRP levels among those individuals
with elevated BP (14, 19, 20). CRP has been reported to
decrease production of nitric oxide by endothelial cells, and
thus might indirectly promote vasoconstriction, leukocyte
adherence, platelet activation, oxidation, and thrombosis. CRP
also has been reported to have proatherosclerotic properties
by upregulating angiotensin type I receptor expression, affect-
ing the renin-angiotensin system and contributing to the
pathogenesis of hypertension (21, 22).
In those studies (14, 19, 20), CRP has been more strongly
associated with systolic BP than diastolic BP, which is con-
sistent with the emerging importance of systolic BP as a
means of cardiovascular risk prediction. But in this study,
diastolic BP was more strongly correlated with CRP than
systolic BP, and BP was not associated with hsCRP in mul-
tivariate analysis.
It is conceivable that components of insulin resistance syn-
drome, such as hypertension, glucose intolerance and dyslipi-
demia promote atherosclerosis which involves inflammatory
process (7). In our study, blood glucose and diastolic blood
pressure was associated with levels of plasma hsCRP.
Smoking is well supposed to give chemical and oxidative
stimuli to the cardiovascular system and cause inflammation
(13). It has recently been reported that moderate alcohol con-
sumptions reduces circulating CRP (23). But in the present
study, when we divided the subjects according to the alcohol
drinking status, the plasma hsCRP level was not significantly
affected by the alcohol drinking.
We know from literature that CRP has been positively
associated with body weight and fatness in men and women
of different ages (24-26). More precisely, central obesity and
the presence of visceral adipose tissue might be a key promoter
of low-grade chronic inflammation (24). Fat cells produce
cytokines, in particular IL-6 that induces the synthesis of CRP
by the liver. This may be of pathogenic significance as CRP
stimulates the uptake of LDL by macrophages, induces com-
plement activation which may cause cellular damage in the
artery, and enhances monocyte production of tissue factor,
thus enhancing the risk of thrombosis (25). A recent study
suggested that both in cross-sectional and in longitudinal
studies body mass index but not physical activity is associ-
ated with CRP (27). These results are similar to the results
we found in multivariate analysis.
We analysed that CRP was negatively related to HDL-
cholesterol in correlational analysis, but it was no longer sig-
nificant after control for other risk factors. The negative asso-
ciation between CRP and HDL-cholesterol might be expla-
ined by interaction between CRP and very low density lipo-
proteins (28).
Several limitations of these data should be taken into acco-
unt. First, because of the cross-sectional design, relationships
between hsCRP and other cardiovascular risk factors cannot
be deemed causal in nature. Additionally, it is impossible that
unmeasured variables may account for the relationships ob-
served. Last, because our study subjects consisted of a relatively
healthy and older volunteer population in a rural area, caution
should be exercised when generalizing these data to other
general populations. Despite these limitations, inherent with
any cross-sectional studies, our results are consistent with
known previous reports and are supported by biological plau-
sibility.
In summary, CRP are independently related to several clin-
ical cardiovascular risk factors among general population in
some rural area. Further what we need now are prospective
studies to evaluate the association of C-reactive protein con-
centrations with subsequent cardiac events.
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